CBS 2019
CBSMD教育中心
English

充血性心力衰竭

科研文章

荐读文献

Rationale and design of the comParIson Of sacubitril/valsartaN versus Enalapril on Effect on nt-pRo-bnp in patients stabilized from an acute Heart Failure episode (PIONEER-HF) trial 3D Printing and Heart Failure: The Present and the Future Clinical epidemiology of heart failure with preserved ejection fraction (HFpEF) in comparatively young hospitalized patients Heart Failure With Preserved Ejection Fraction in the Young Vaccination Trends in Patients With Heart Failure - Insights From Get With The Guidelines–Heart Failure In acute HF and iron deficiency, IV ferric carboxymaltose reduced HF hospitalizations, but not CV death, at 1 y 中国心力衰竭诊断和治疗指南2018 Impact of Myocardial Scar on Prognostic Implication of Secondary Mitral Regurgitation in Heart Failure A randomized controlled trial to evaluate the safety and efficacy of cardiac contractility modulation in patients with systolic heart failure: rationale, design, and baseline patient characteristics. Effects of Dapagliflozin on Symptoms, Function and Quality of Life in Patients with Heart Failure and Reduced Ejection Fraction: Results from the DAPA-HF Trial

Original Research2018 Apr;198:145-151.

JOURNAL:Am J Cardiol. Article Link

Rationale and design of the comParIson Of sacubitril/valsartaN versus Enalapril on Effect on nt-pRo-bnp in patients stabilized from an acute Heart Failure episode (PIONEER-HF) trial

Velazquez EJ, Morrow DA, DeVore AD et al. Keywords: sacubitril; valsartan; enalapril; NT-proBNP; acute Heart Failure episode

FULL TEXT PDF